Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherry J Morgan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Veterinary Research|July 15, 2003
Submural histopathologic changes attributable to peracute laminitis in horsesSherry J Morgan, David M Hood, Ilka P Wagner, et al.
Toxicologic Pathology|September 22, 2016
Copovidone-related Cutaneous Response in the DogSherry J Morgan, Lauren M Besenhofer, Wayne Buck, et al.
Analytical Chemistry|September 1, 2005
Investigation of the immunogenicity of a protein drug using equilibrium dialysis and liquid chromatography tandem mass spectrometry detectionQin C Ji, Ramona Rodila, Sherry J Morgan, et al.
Toxicologic Pathology|September 13, 2012
Use of animal models of human disease for nonclinical safety assessment of novel pharmaceuticalsSherry J Morgan, Chandikumar S Elangbam, Shawn Berens, et al.
Toxicologic Pathology|March 30, 2017
Regulatory Forum Opinion Piece<sup>*</sup>: Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry SurveySherry J Morgan, Jessica Couch, Peggy Guzzie-Peck, et al.
Journal of Pathology Informatics|May 23, 2012
Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure modelsMarcin Klapczynski, Gerard D Gagne, Sherry J Morgan, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 11, 2006
Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcificationJ Ruth Wu-Wong, William Noonan, Junli Ma, et al.
Anti-Cancer Drugs|April 29, 2009
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculatureYanping Luo, Vincent P Hradil, David J Frost, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Delivery of RNAi reagents in murine models of obesity and diabetesDenise M Wilcox, Ruojing Yang, Sherry J Morgan, et al.
Cancer Research|November 25, 2003
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2Jieyi Wang, George S Sheppard, Pingping Lou, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Veterinary Research|July 15, 2003
Submural histopathologic changes attributable to peracute laminitis in horsesSherry J Morgan, David M Hood, Ilka P Wagner, et al.
Toxicologic Pathology|September 22, 2016
Copovidone-related Cutaneous Response in the DogSherry J Morgan, Lauren M Besenhofer, Wayne Buck, et al.
Analytical Chemistry|September 1, 2005
Investigation of the immunogenicity of a protein drug using equilibrium dialysis and liquid chromatography tandem mass spectrometry detectionQin C Ji, Ramona Rodila, Sherry J Morgan, et al.
Toxicologic Pathology|September 13, 2012
Use of animal models of human disease for nonclinical safety assessment of novel pharmaceuticalsSherry J Morgan, Chandikumar S Elangbam, Shawn Berens, et al.
Toxicologic Pathology|March 30, 2017
Regulatory Forum Opinion Piece<sup>*</sup>: Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry SurveySherry J Morgan, Jessica Couch, Peggy Guzzie-Peck, et al.
Journal of Pathology Informatics|May 23, 2012
Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure modelsMarcin Klapczynski, Gerard D Gagne, Sherry J Morgan, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 11, 2006
Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcificationJ Ruth Wu-Wong, William Noonan, Junli Ma, et al.
Anti-Cancer Drugs|April 29, 2009
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculatureYanping Luo, Vincent P Hradil, David J Frost, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Delivery of RNAi reagents in murine models of obesity and diabetesDenise M Wilcox, Ruojing Yang, Sherry J Morgan, et al.
Cancer Research|November 25, 2003
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2Jieyi Wang, George S Sheppard, Pingping Lou, et al.
Pageof 2